Skip to Content

Head & Neck-Post-Operative Radiation Therapy (IMRT) +/- Cetuximab


RTOG 0920 A Phase III Study of Post-Operative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

The purpose of this study is to compare the effects, good and/or bad, of radiation therapy alone with radiation therapy and cetuximab the cancer to find out which is better.  Patients will receive either radiation therapy alone OR radiation therapy and cetuximab.

Rebecca Denofer, RN, OCN at 802-747-1692

RUTLAND REGIONAL MEDICAL CENTER160 Allen Street, Rutland, VT 05701802.775.7111

© 2022 Rutland Medical Center